Englander Institute for Precision Medicine

Developmental chromatin programs determine oncogenic competence in melanoma.

TitleDevelopmental chromatin programs determine oncogenic competence in melanoma.
Publication TypeJournal Article
Year of Publication2021
AuthorsBaggiolini A, Callahan SJ, Montal E, Weiss JM, Trieu T, Tagore MM, Tischfield SE, Walsh RM, Suresh S, Fan Y, Campbell NR, Perlee SC, Saurat N, Hunter MV, Simon-Vermot T, Huang T-H, Ma Y, Hollmann T, Tickoo SK, Taylor BS, Khurana E, Koche RP, Studer L, White RM
JournalScience
Volume373
Issue6559
Paginationeabc1048
Date Published2021 Sep 03
ISSN1095-9203
KeywordsAnimals, Animals, Genetically Modified, ATPases Associated with Diverse Cellular Activities, Carcinogenesis, Chromatin, DNA-Binding Proteins, Humans, Melanocytes, Melanoma, Mice, Neoplasms, Experimental, Neoplastic Stem Cells, Neural Crest, Pluripotent Stem Cells, Proto-Oncogene Proteins B-raf, SOXE Transcription Factors, Transcription, Genetic, Zebrafish
Abstract

Oncogenes only transform cells under certain cellular contexts, a phenomenon called oncogenic competence. Using a combination of a human pluripotent stem cell–derived cancer model along with zebrafish transgenesis, we demonstrate that the transforming ability of BRAF along with additional mutations depends on the intrinsic transcriptional program present in the cell of origin. In both systems, melanocytes are less responsive to mutations, whereas both neural crest and melanoblast populations are readily transformed. Profiling reveals that progenitors have higher expression of chromatin-modifying enzymes such as ATAD2, a melanoma competence factor that forms a complex with SOX10 and allows for expression of downstream oncogenic and neural crest programs. These data suggest that oncogenic competence is mediated by regulation of developmental chromatin factors, which then allow for proper response to those oncogenes.

DOI10.1126/science.abc1048
Alternate JournalScience
PubMed ID34516843
PubMed Central IDPMC9440978
Grant ListF30 CA220954 / CA / NCI NIH HHS / United States
K08 AR055368 / AR / NIAMS NIH HHS / United States
P30 CA008748 / CA / NCI NIH HHS / United States
T32 GM008539 / GM / NIGMS NIH HHS / United States
R01 CA238317 / CA / NCI NIH HHS / United States
F32 MH116590 / MH / NIMH NIH HHS / United States
F30 CA236442 / CA / NCI NIH HHS / United States
K00 CA223016 / CA / NCI NIH HHS / United States
T32 GM007739 / GM / NIGMS NIH HHS / United States
F31 CA196305 / CA / NCI NIH HHS / United States
R01 CA229215 / CA / NCI NIH HHS / United States
DP2 CA186572 / CA / NCI NIH HHS / United States

Weill Cornell Medicine Englander Institute for Precision Medicine 413 E 69th Street
Belfer Research Building
New York, NY 10021